Paper12205652
LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures.
Gu W and 2 others. Ann Neurol, 2002. Cited by 121 papers, by iCite.
Cite this record
ConductScience Library. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Papers, record 12205652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12205652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aphasia | Major topic |
| Epilepsy, Temporal Lobe | Major topic |
| Mutation, Missense | Major topic |
| Proteins | Major topic |
| DNA Mutational Analysis | |
| Family Health | |
| Female | |
| Humans | |
| Intracellular Signaling Peptides and Proteins | |
| Male | |
| Norway | |
| Pedigree |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40601686 | Structural insights into heterohexameric assembly of epilepsy-related ligand-receptor complex LGI1-ADAM22. | Elife | 2025 | https://conductscience.org/library/papers/40601686 | PubMed |
| 40455867 | Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1-ADAM22/23 pathway. | Brain | 2025 | https://conductscience.org/library/papers/40455867 | PubMed |
| 37658249 | Clinical Correlation of Altered Molecular Signatures in Epileptic Human Hippocampus and Amygdala. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/37658249 | PubMed |
| 36804022 | A patient-derived mutation of epilepsy-linked LGI1 increases seizure susceptibility through regulating Kv1.1. | Cell Biosci | 2023 | https://conductscience.org/library/papers/36804022 | PubMed |
| 35153984 | Epilepsy With Auditory Features: From Etiology to Treatment. | Front Neurol | 2021 | https://conductscience.org/library/papers/35153984 | PubMed |
| 34767694 | A novel LGI1 mutation causing autosomal dominant lateral temporal lobe epilepsy confirmed by a precise knock-in mouse model. | CNS Neurosci Ther | 2022 | https://conductscience.org/library/papers/34767694 | PubMed |
| 31432233 | Insights into the mechanisms of epilepsy from structural biology of LGI1-ADAM22. | Cell Mol Life Sci | 2020 | https://conductscience.org/library/papers/31432233 | PubMed |
| 31105945 | Clinical variants of limbic encephalitis. | SAGE Open Med Case Rep | 2019 | https://conductscience.org/library/papers/31105945 | PubMed |
| 30692776 | Leucine-Rich Glioma-Inactivated Protein 1 Antibody-Positive Limbic Encephalitis in a Patient with Adenocarcinoma of Prostate: A Case Report. | Ann Indian Acad Neurol | 2019 | https://conductscience.org/library/papers/30692776 | PubMed |
| 30034322 | Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination via TSC-mTOR Signaling. | Front Mol Neurosci | 2018 | https://conductscience.org/library/papers/30034322 | PubMed |
| 29670100 | Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22. | Nat Commun | 2018 | https://conductscience.org/library/papers/29670100 | PubMed |
| 29397673 | Limbic Encephalitis Manifesting as Selective Amnesia and Seizure-like Activity: A Case Report. | Clin Psychopharmacol Neurosci | 2018 | https://conductscience.org/library/papers/29397673 | PubMed |
| 27822050 | Autoimmune encephalitis in psychiatric institutions: current perspectives. | Neuropsychiatr Dis Treat | 2016 | https://conductscience.org/library/papers/27822050 | PubMed |
| 27781030 | Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects. | Mol Syndromol | 2016 | https://conductscience.org/library/papers/27781030 | PubMed |
| 26633957 | "Fold Here"-Chemical Correctors in the Treatment of Epilepsy. | Epilepsy Curr | 2015 | https://conductscience.org/library/papers/26633957 | PubMed |
| 26275289 | Curation of the Mammalian Palmitoylome Indicates a Pivotal Role for Palmitoylation in Diseases and Disorders of the Nervous System and Cancers. | PLoS Comput Biol | 2015 | https://conductscience.org/library/papers/26275289 | PubMed |
| 25591666 | Essential roles of leucine-rich glioma inactivated 1 in the development of embryonic and postnatal cerebellum. | Sci Rep | 2015 | https://conductscience.org/library/papers/25591666 | PubMed |
| 25526788 | Function and mechanism of tumor suppressor gene LRRC4/NGL-2. | Mol Cancer | 2014 | https://conductscience.org/library/papers/25526788 | PubMed |
| 25491076 | Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. | J Neurol | 2015 | https://conductscience.org/library/papers/25491076 | PubMed |
| 25485908 | Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy. | Nat Med | 2015 | https://conductscience.org/library/papers/25485908 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LGI1 | 9211 | Swiss-Prot's references | https://conductscience.org/library/genes/9211 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12205652
GET https://conductscience.org/api/papers/v1/12205652/cited_by?page=2